Papua New Guinea vs Uruguay: Average non-HDL cholesterol levels
Papua New Guinea
3.6
in 2018
Uruguay
3.6
in 2018
Papua New Guinea rank
30th
Uruguay rank
30th
Average non-HDL cholesterol levels over time
- Papua New Guinea
- Uruguay
How they compare
Papua New Guinea currently reports 3.6 against 3.6 in Uruguay, a difference of 0.
Across all 39 years both countries report, Uruguay has been ahead every year.
Papua New Guinea ranks 30th and Uruguay ranks 30th of 191 countries.
Uruguay has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Papua New Guinea | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.33 | 3.95 | 0.62 | Uruguay |
| 1990s | 3.48 | 3.78 | 0.3 | Uruguay |
| 2000s | 3.54 | 3.66 | 0.12 | Uruguay |
| 2010s | 3.6 | 3.6 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Papua New Guinea or Uruguay?
- Papua New Guinea, at 3.6 against 3.6 in Uruguay as of 2018.
- What is the difference in average non-hdl cholesterol levels between Papua New Guinea and Uruguay?
- 0, with Papua New Guinea ahead.
- How many years of comparable data are there for Papua New Guinea and Uruguay?
- 39 years are reported by both, from 1980 to 2018.
- How do Papua New Guinea and Uruguay rank globally for average non-hdl cholesterol levels?
- Papua New Guinea ranks 30th and Uruguay ranks 30th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.